PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

0.3031

-0.0122 (-3.87%)

At close: Sep 11, 2026, 4:00 PM EDT

0.2900

-0.0131 (-4.32%)

After-hours: Sep 11, 2026, 5:29 PM EDT

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.6	26.71	41.69	56.56	73.82	65.24
Cash & Short-Term Investments	5.6	26.71	41.69	56.56	73.82	65.24
Cash Growth	-82.44%	-35.93%	-26.29%	-23.38%	13.15%	126.23%
Prepaid Expenses	1.45	1.54	3.36	2.49	2.66	1.6
Total Current Assets	7.05	28.25	45.05	59.06	76.48	66.84
Property, Plant & Equipment	0.21	0.24	0.3	0.34	0.53	0.36
Other Long-Term Assets	1.55	2	-	-	-	-
Total Assets	8.81	30.49	45.36	59.39	77.01	67.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.39	3.57	1.68	6.98	1.22	1.31
Accrued Expenses	1.63	0.74	2.84	2.42	8.31	2.19
Short-Term Debt	-	5.13	12.5	4.17	-	-
Current Portion of Leases	0.03	0.04	0.06	0.06	0.29	0.26
Total Current Liabilities	12.38	9.48	17.09	13.63	9.82	3.76
Long-Term Debt	-	11.73	9.2	19.51	23.02	-
Long-Term Leases	0.01	0.03	0.06	0.12	0.16	0.23
Total Liabilities	12.39	21.24	26.35	33.26	33.01	3.99

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	230.11	225.84	201.1	170.62	145.55	123.9
Retained Earnings	-233.71	-216.61	-182.11	-144.5	-101.56	-60.7
Shareholders' Equity	-3.58	9.25	19	26.13	44	63.21
Total Liabilities & Equity	8.81	30.49	45.36	59.39	77.01	67.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	4.36	16.93	21.83	23.85	23.47	0.49
Net Cash (Debt)	1.23	9.79	19.86	32.71	50.35	64.75
Net Cash Growth	-90.76%	-50.73%	-39.28%	-35.03%	-22.25%	129.38%
Net Cash Per Share	0.02	0.21	0.54	1.06	1.76	2.53
Filing Date Shares Outstanding	55.97	55.82	45.4	36.68	30.72	28.45
Total Common Shares Outstanding	55.92	54.88	37.99	33.09	30.17	28.45
Working Capital	-5.33	18.77	27.97	45.43	66.66	63.08
Book Value Per Share	-0.06	0.17	0.50	0.79	1.46	2.22
Tangible Book Value	-3.58	9.25	19	26.13	44	63.21
Tangible Book Value Per Share	-0.06	0.17	0.50	0.79	1.46	2.22
Machinery	-	0.3	0.3	0.27	0.12	0.12

SEC Filings: 10-K · 10-Q